409 related articles for article (PubMed ID: 8593783)
1. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
[TBL] [Abstract][Full Text] [Related]
4. Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-I receptor abolishes autophosphorylation but does not eliminate biologic function.
Blakesley VA; Kato H; Roberts CT; LeRoith D
J Biol Chem; 1995 Feb; 270(6):2764-9. PubMed ID: 7852347
[TBL] [Abstract][Full Text] [Related]
5. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation.
Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR
Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864
[TBL] [Abstract][Full Text] [Related]
6. Single tyrosine substitution in the insulin-like growth factor I receptor inhibits ligand-induced receptor autophosphorylation and internalization, but not mitogenesis.
Stannard B; Blakesley V; Kato H; Roberts CT; LeRoith D
Endocrinology; 1995 Nov; 136(11):4918-24. PubMed ID: 7588225
[TBL] [Abstract][Full Text] [Related]
7. The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tumorigenesis.
Hernández-Sánchez C; Blakesley V; Kalebic T; Helman L; LeRoith D
J Biol Chem; 1995 Dec; 270(49):29176-81. PubMed ID: 7493944
[TBL] [Abstract][Full Text] [Related]
8. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth.
Blakesley VA; Koval AP; Stannard BS; Scrimgeour A; LeRoith D
J Biol Chem; 1998 Jul; 273(29):18411-22. PubMed ID: 9660809
[TBL] [Abstract][Full Text] [Related]
9. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine.
Ando A; Momomura K; Tobe K; Yamamoto-Honda R; Sakura H; Tamori Y; Kaburagi Y; Koshio O; Akanuma Y; Yazaki Y
J Biol Chem; 1992 Jun; 267(18):12788-96. PubMed ID: 1618780
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
Valverde AM; Teruel T; Lorenzo M; Benito M
Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor.
Giorgetti S; Pelicci PG; Pelicci G; Van Obberghen E
Eur J Biochem; 1994 Jul; 223(1):195-202. PubMed ID: 8033892
[TBL] [Abstract][Full Text] [Related]
12. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
Miura M; Li S; Baserga R
Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
[TBL] [Abstract][Full Text] [Related]
13. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit.
Najjar SM; Blakesley VA; Li Calzi S; Kato H; LeRoith D; Choice CV
Biochemistry; 1997 Jun; 36(22):6827-34. PubMed ID: 9184166
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I signalling through heterodimers of insulin and insulin-like growth factor I receptors.
Takata Y; Kobayashi M
Diabete Metab; 1994; 20(1):31-6. PubMed ID: 8056133
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
17. NPXY motif in the insulin-like growth factor-I receptor is required for efficient ligand-mediated receptor internalization and biological signaling.
Hsu D; Knudson PE; Zapf A; Rolband GC; Olefsky JM
Endocrinology; 1994 Feb; 134(2):744-50. PubMed ID: 8299569
[TBL] [Abstract][Full Text] [Related]
18. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.
Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194
[TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor stimulates DNA synthesis in cells overexpressing the insulin-like growth factor-I receptor.
Yoshinouchi M; Miura M; Gaozza E; Li SW; Baserga R
Mol Endocrinol; 1993 Sep; 7(9):1161-8. PubMed ID: 8247018
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase.
Grønborg M; Wulff BS; Rasmussen JS; Kjeldsen T; Gammeltoft S
J Biol Chem; 1993 Nov; 268(31):23435-40. PubMed ID: 7693688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
